Spectrum Pharmaceuticals, Inc.
NASDAQ: SPPI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Thomas J. Riga
- Employees
- 86
- Headquarters
- Boston, United States
- IPO year
- 1996
- Market cap
- $210.4M
- Website
- https://www.sppirx.com
Loading SPPI…
Loading profile data…Frequently asked questions about SPPI
What does Spectrum Pharmaceuticals, Inc. (SPPI) do?
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induce...
Where does SPPI trade?
Spectrum Pharmaceuticals, Inc. (SPPI) trades on the NASDAQ Global Select.
What sector is SPPI in?
Spectrum Pharmaceuticals, Inc. (SPPI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Spectrum Pharmaceuticals, Inc.?
Thomas J. Riga is the chief executive officer of Spectrum Pharmaceuticals, Inc. (SPPI).
Where is Spectrum Pharmaceuticals, Inc. headquartered?
Spectrum Pharmaceuticals, Inc. is headquartered in United States.
Does SPPI pay a dividend?
Yes — Spectrum Pharmaceuticals, Inc. (SPPI) paid a trailing twelve-month dividend of USD 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SPPI go public?
Spectrum Pharmaceuticals, Inc. (SPPI) completed its initial public offering in 1996.